Journal Basic Info
- Impact Factor: 1.809**
- H-Index: 6
- ISSN: 2474-1655
- DOI: 10.25107/2474-1655
Major Scope
- Biochemistry and Biostatistics
- Women’s Health Care
- Pneumonia
- Sports Medicine
- Orthopedics & Rheumatology
- Pharmacology and Therapeutics
- Asthma
- Renal Disease
Abstract
Citation: Ann Clin Case Rep. 2020;5(1):1808.DOI: 10.25107/2474-1655.1808
DNAH5, A Possible Genetic Marker in Diagnosing Connective Tissue Disease-Associate Interstitial Lung Disease (CTD-ILD)
Jie Zhao, Yan Zhu, Qun Jin, Wenyuan Duan and Li Yang
Department of Pulmonary and Critical Care Medicine, Zhejiang Shuren University, China
PDF Full Text Case Report | Open Access
Abstract:
Connective Tissue Disease-associate Interstitial Lung Disease (CTD-ILD) treatment depends on early accurate diagnosis. We hereby report a case of a 66-year-old man who has been diagnosed with CTD-ILD according to his High Resolution Computed Tomography (HRCT) and symptoms. In the meantime, we find axonemal dynein heavy chain gene 5 (DNAH5) variants in his Whole-Exome Sequence (WES). We wonder if DNAH5 is a biomarker of CTD-ILD.
Keywords:
Cite the Article:
Zhao J, Zhu Y, Jin Q, Duan W, Yang L. DNAH5, A Possible Genetic Marker in Diagnosing Connective Tissue Disease- Associate Interstitial Lung Disease (CTD-ILD). Ann Clin Case Rep. 2020; 5: 1808.
